ATC
IBB icon

Argent Trust Co’s iShares Biotechnology ETF IBB Stock Holding History

Argent Trust Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$289K Buy
1,712
+100
+6% +$17.1K 0.01% 618
2025
Q4 		$272K Sell
1,612
-21
-1% -$3.41K 0.01% 613
2025
Q3 		$236K Buy
1,633
+21
+1% +$2.87K 0.01% 636
2025
Q2 		$204K Hold
1,612
– – 0.01% 667
2025
Q1 		$206K Buy
1,612
+35
+2% +$4.75K 0.01% 657
2024
Q4 		$208K Buy
1,577
+40
+3% +$5.62K 0.01% 657
2024
Q3 		$224K Sell
1,537
-50
-3% -$7.24K 0.01% 633
2024
Q2 		$218K Hold
1,587
– – 0.01% 632
2024
Q1 		$218K Buy
+1,587
New +$217K 0.01% 634

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Argent Trust Co's IBB Position: Q1 2026 in Review

Argent Trust Co increased its iShares Biotechnology ETF (IBB) stake by 6.2% in Q1 2026, buying an estimated $17.1K and bringing the position to 1,712 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #618.

Argent Trust Co first reported a position in IBB in Q1 2024 and has held it in 9 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Argent Trust Co held 1,712 shares of iShares Biotechnology ETF worth $289K as of Q1 2026.
  • Argent Trust Co bought 100 iShares Biotechnology ETF shares in Q1 2026, an estimated $17.1K.
  • iShares Biotechnology ETF made up 0.01% of Argent Trust Co's portfolio in Q1 2026, its #618 holding.
  • Argent Trust Co first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 9 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.